Vivodyne

San Francisco, United States

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

$40.0M raised

May 2025

Series A

Top Investors

Khosla VenturesBison VenturesKairos VenturesMBX CapitalLingotto

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vivodyne raised?

Vivodyne has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.

Who are Vivodyne's investors?

Vivodyne's investors include Khosla Ventures, Bison Ventures, Kairos Ventures, MBX Capital, Lingotto.

Where is Vivodyne headquartered?

Vivodyne is headquartered in San Francisco, United States.

What does Vivodyne do?

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

What stage is Vivodyne at?

Vivodyne is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 29, 2025.

MLA

"Vivodyne — Funding & Investors." VCBacked, May 29, 2025, https://www.vcbacked.co/company/vivodyne. Accessed June 4, 2026.

APA

VCBacked. (2025). Vivodyne — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vivodyne

Wikipedia (cite web)

{{cite web |title=Vivodyne — Funding & Investors |url=https://www.vcbacked.co/company/vivodyne |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 29, 2025.